CLINICAL_TRIALS
trial_result
· 2026-04-23
Clinical Trial Update: A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
Summary
A Phase 2 clinical trial to evaluate LTI-03 for idiopathic pulmonary fibrosis is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rein Therapeutics | Conditions: Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 | Status: RECRUITING